QuadMedicine, Inc. (KOSDAQ:464490)

Market Cap	200.18B
Revenue (ttm)	13.11B +195.5%
Net Income	-5.49B
EPS	-592.68
Shares Out	11.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	487,016
Average Volume	1,790,341
Open	18,500
Previous Close	n/a
Day's Range	17,690 - 19,290
52-Week Range	12,460 - 27,150
Beta	n/a
RSI	54.07
Earnings Date	n/a

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 464490